Successful British cyclist, Chris Froome, is left fighting for his career after being notified of an Adverse Analytical Finding (AAF), the Union Cycliste Internationale (UCI) confirmed today.
Froome’s urine sample, taken during his first win at Vuelta a Espana in September, returned double the legal amount of asthma medication, Salbutamol – in excess of 1 000 nanograms per millilitre.
The failed ‘drug’ test places his Tour de Spain title in jeopardy.
Froome, who also won his fourth Tour de France in July, was originally notified of the AAF on September 20.
The 32-year-old Team Sky rider has not competed since the above mentioned date.
Team Sky had released a statement saying, “Chris has had asthma since childhood and uses an inhaler to take a common medication.”
In the same statement, Froome said he was well aware of the rules.
“It is well known that I have asthma,” he said. “I use an inhaler to manage my symptoms and I know for sure that I will be tested every day I wear the race leader’s jersey.”
No suspension has yet been given.